Uneven Pattern of Dopamine Loss in the Striatum with Idiopathic Parkinson's Disease, Pathophysiologic & Clinical Implications
NEJM 318:876-880, Kish,S.J., 1988
A Study of Facial Expression in Parkinson's Disease Using a Novel Microcomputer-Based Method
JNNP 51:362-366, Katsikitis,M.&Pilowsky,I., 1988
Tetrabenazine Therapy of Dystonia, Chorea, Tics, & Other Dyskinesias
Neurol 38:391-394, Jankovic,J.&Orman,J., 1988
Drug-Induced Alzheimerism
Arch Neurol 45:356-357, Kurlan,R.&Como,P., 1988
International Symposium on Early Dopamine Agonist Therapy of Parkinson's Disease
Arch Neurol 45:204-208, Kurlan,R., 1988
Extrapyramidal Reactions to Anti-Inflammatory Drugs
JNNP 51:731-732, Wood,N.,et al, 1988
Basal Ganglia Involvement in Subacute Sclerosing Panencephalitis:CT and MR Demonstration
J Comput Assist Tomogr 12:489-491, Woodward,K.G.,et al, 1988
Extrapyramidal and Other Neurologic Manifestations Associated with Carbon Disulfide Fumigant Exposure
Arch Neurol 45:537-540, Peters,H.A.,et al, 1988
Parkinsonian Syndrome Caused by a Tumour of the Left Supplementary Motor Area
JNNP 51:730-731, Straube,A.&Sigel,K., 1988
A Comparison of Clinical and Pathological Features of Young-and Old-Onset Parkinson's Disease
Neurol 38:1402-1406, Gibb,W.R.G.&Lees,A.J., 1988
Subcutaneous Apomorphine in Parkinsonian On-Off Oscillations
Lancet 1:403-406, Stibe,C.M.H.,et al, 1988
Dystonia in Parkinson's Disease:Clinical & Pharmacological Features
Ann Neurol 23:73-78, Poewe,W.H.,et al, 1988
An Estimate of the Prevalence of Dementia in Idiopathic Parkinson's Disease
Arch Neurol 45:260-262, Mayeux,R.,et al, 1988
A Double-Blind Trial of Clonazepam in the Treatment of Parkinsonian Dysarthria
Neurol 38:255-258, Biary,N.,et al, 1988
Transplantation of Fetal Substantia Nigra & Adrenal Medulla to the Caudate Nucleus in Two Patients with Parkinson's Disease
NEJM 318:51, Madrazo,I.,et al, 1988
Decreased Catecholamines in the Adrenal Medulla of Patients with Parkinsonism
NEJM 318:254, Carmichael,S.W.,et al, 1988
Protein Redistribution Diet Restores Motor Function in Patients with Dopa-Resistant"Off"Periods
Neurol 38:481-483, Pincus,J.H.&Barry,K., 1988
Prevalence and Natural History of Progressive Supranuclear Palsy
Neurol 38:1031-1034, Golbe,L.I.,et al, 1988
Cerebral Hypometabolism in Progressive Supranuclear Palsy Studied with Positron Emission Tomography
Ann Neurol 24:399-406, Foster,N.L.,et al, 1988
Neuroleptic-Induced Parkinson's Syndrome:Clinical Features and Results of Treatment with Levodopa
JNNP 51:850-854, Hardie,R.J.&Lees,A.J., 1988
Dystonic-Parkinsonian Syndrome after Cyanide Poisoning:Clinical and MRI Findings
JNNP 51:1345-1348, Carella,F.,et al, 1988
Treatment of Dopaminomimetic Psychosis in Parkinson's Disease with Electroconvulsive Therapy
Can J Neurol Sci 15:32-34, Hurwitz,T.A.&Waterman,C., 1988
A Creutzfeldt-Jakob Like Syndrome Due to Lithium Toxicity
JNNP 51:120-123, Smith,S.J.M.&Kocen,R.S., 1988
Creutzfeldt-Jakob Disease without Periodic Sharp Wave Complexes:A Clinical, EEG, and Path Study
Neurol 38:1056-1060, Zochodne,D.W.,et al, 1988
Observations on the Applicability of the Wartenberg Pendulum Test to Healthy, Elderly Subjects
JNNP 51:1171-1177, Brown,R.A.,et al, 1988
Classification of Parkinsonism
in Handbook of Parkinson's Disease, Marcel Dekker, Inc, New York, Ch 3, p 61., Koller,W.C., 1987
Pathophysiology & Clinical Assessment of Motor Symptoms in Parkinson's Disease
In Handbk of Parkinson's Disease, Marcel Dekker, Inc, New York, p997., Jankovic,J., 1987
Factors that Influence the Occurrence of Response Variations in Parkinson's Disease
Ann Neurol 22:4-7, deJong,G.J.,et al, 1987
Multi-Center Study of Parkinson Mortality with Early Versus Later Dopa Treatment
Ann Neurol 22:8-12, Diamond,S.G.,et al, 1987
Adjuvant Therapy of Parkinsonian Tremor
Arch Neurol 44:921-923, Koller,W.C.&Herbster,G., 1987
Neuropsychological Disturbances in Hemiparkinson's Disease
Neurol 37:1762-1764, Starkstein,S.,et al, 1987
Parkinson's Disease:Sensory & Motor Problems in Arms & Hands
Neurol 37:951-956, Schneider,J.S.,et al, 1987
Early Combination of Bromocriptine & Levodopa in the Treatment of Parkinson's Disease:A 5-Year Follow-up
Neurol 37:826-828, Rinne,U.K., 1987
Bromocriptine Induced Impotence in Parkinson's Disease
BMJ 295:367-368, Cleves,L., 1987
Forms of Dystonia in Patients with Parkinson's Disease
Neurol 37:1009-1011, Kidron,D.&Melamed,E., 1987
Clinical & Biochemical Correlates of Bradyphrenia in Parkinson's Disease
Neurol 37:1130-1134, Mayeux,R.,et al, 1987
Neuropathologic & Clinical Features of Parkinson's Disease in Alzheimer's Disease Patients
Neurol 37:754-760, Ditter,S.M.&Mirra,S.S., 1987
Reaction Times & Attention in Parkinson's Disease
JNNP 50:1178-1183, Bloxham,C.A.,et al, 1987
The Aetiology of Mirror Writing:A New Hypothesis
JNNP 50:1572-1578, Tashiro,K.,et al, 1987
Disorders of the Autonomic Nervous System:Part 1. Pathophysiology & Clinical Features
Ann Neurol 21:419-430, McLeod,J.G.&Tuck,R.R., 1987
Perseveration in Behavioral Neurology
Neurol 37:1736-1741, Sandson,J.&Albert,M.L., 1987
Limb Dystonia in Progressive Supranuclear Palsy
Neurol 37:1546-1549, Rafal,R.D.&Friedman,J.H., 1987
Extrapyramidal Disturbances Caused by Inappropriate Prescribing
BMJ 295:30-31, Pall,H.S.&Williams,A.C., 1987
Flunarizine- & -Cinnarizine-Induced Extrapyramidal Reactions
Neurol 37:881-884, Micheli,F.,et al, 1987
Aggravation of Parkinson's Disease by Cinnarizine
JNNP 50:804-805, Marti-Masso,J.F.,et al, 1987
Neurological Clues from Environmental Neurotoxins
BMJ 295:346-347, Martyn,C.N., 1987
Adrenal Grafts for Parkinson's Disease
Letter, NEJM 317:1091-10931987., , 1987
Transplantation in Parkinson's Disease:Two Cases of Adrenal Medullary Grafts to the Putamen
Ann Neurol 22:457-468, Lindvall,O.,et al, 1987
Neural Transplants:Are We Ready
Ann Neurol 22:455-456, Joynt,R.J.&Gash,D.M., 1987
Management of Parkinson's Disease
BMJ 294:1393-1396, Gibberd,F.B., 1987